Literature DB >> 11078120

Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

R Thiébaut 1, D Malvy, C Marimoutou, F Davis.   

Abstract

The aim of the study was to assess the performance of weight related nutritional markers [reported involuntary weight loss (WL) greater than 10%, measured WL and body mass index (BMI)] in predicting survival at AIDS stage. The three anthropometric indices were used as time dependent variables in Cox models to predict survival at AIDS stage. The studied sample included 630 HIV1-infected individuals of a prospective cohort of those 421 died (median survival at AIDS stage: 19.9 months). After adjustment for usual prognostic factors of survival, the reported WL greater than 10% was a pejorative predictor of survival (hazard ratio (HR) 2.4; 95% confidence interval (CI): 1.9-3.0). For measured WL < 5%, between 5 and 10% and > or = 10% of baseline weight compared with no WL, HR were respectively, 1.9 (CI: 1.4-2.6), 3.3 (CI: 2.4-4.4) and 6.7 (CI: 5.2-8.6). The HR of death were 2.2 (CI: 1.6-3.0) for BMI between 16 and 18.4 kg/m2 and 4.4 (CI: 3.1-6.3) for BMI < 16 compared to normal BMI (> or = 18.5). Even a limited WL measured at a given point in time during follow up increases the risk of death at the AIDS stage. Simple cross-sectional measures of BMI have a good predictive value of survival.

Entities:  

Mesh:

Year:  2000        PMID: 11078120     DOI: 10.1023/a:1007696530440

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  35 in total

1.  Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height.

Authors:  F J Nieto-García; T L Bush; P M Keyl
Journal:  Epidemiology       Date:  1990-03       Impact factor: 4.822

2.  Factors affecting survival in patients with the acquired immunodeficiency syndrome.

Authors:  A Mocroft; M A Johnson; A N Phillips
Journal:  AIDS       Date:  1996-09       Impact factor: 4.177

3.  Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.

Authors:  A J Mocroft; J D Lundgren; A d'Armino Monforte; B Ledergerber; S E Barton; S Vella; C Katlama; J Gerstoft; C Pedersen; A N Phillips
Journal:  Int J Epidemiol       Date:  1997-04       Impact factor: 7.196

4.  Slim disease: a new disease in Uganda and its association with HTLV-III infection.

Authors:  D Serwadda; R D Mugerwa; N K Sewankambo; A Lwegaba; J W Carswell; G B Kirya; A C Bayley; R G Downing; R S Tedder; S A Clayden; R A Weiss; A G Dalgleish
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

5.  Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients.

Authors:  J C Melchior; T Niyongabo; D Henzel; I Durack-Bown; S C Henri; A Boulier
Journal:  Nutrition       Date:  1999 Nov-Dec       Impact factor: 4.008

6.  A simplified approach of assessing adult chronic energy deficiency.

Authors:  A Ferro-Luzzi; S Sette; M Franklin; W P James
Journal:  Eur J Clin Nutr       Date:  1992-03       Impact factor: 4.016

7.  Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL.

Authors:  E G Apolonio; D R Hoover; Y He; A J Saah; D W Lyter; R Detels; R A Kaslow; J P Phair
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

8.  Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators.

Authors:  J P Palenicek; N M Graham; Y D He; D A Hoover; J S Oishi; L Kingsley; A J Saah
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-11-01

9.  HIV wasting syndrome in the United States.

Authors:  B L Nahlen; S Y Chu; O C Nwanyanwu; R L Berkelman; S A Martinez; J V Rullan
Journal:  AIDS       Date:  1993-02       Impact factor: 4.177

10.  Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study.

Authors:  B H van Benthem; P J Veugelers; P G Cornelisse; S A Strathdee; J M Kaldor; K A Shafer; R A Coutinho; G J van Griensven
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

View more
  13 in total

1.  Health & nutritional status of HIV infected children.

Authors:  Rakesh Lodha; S K Kabra
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

2.  Nutritional aspects of HIV-associated wasting in sub-Saharan Africa.

Authors:  John R Koethe; Douglas C Heimburger
Journal:  Am J Clin Nutr       Date:  2010-02-10       Impact factor: 7.045

3.  Disrupted anabolic and catabolic processes may contribute to alcohol-accentuated SAIDS-associated wasting.

Authors:  Nicole J LeCapitaine; Zhong Q Wang; Jason P Dufour; Barry J Potter; Gregory J Bagby; Steve Nelson; William T Cefalu; Patricia E Molina
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

4.  Associations of Body Mass Index and Waist Circumference with 3-Year All-Cause Mortality Among the Oldest Old: Evidence from a Chinese Community-Based Prospective Cohort Study.

Authors:  Yue-Bin Lv; Simin Liu; Zhao-Xue Yin; Xiang Gao; Virginia Byers Kraus; Chen Mao; Jin-Qiu Yuan; Juan Zhang; Jie-Si Luo; Hua-Shuai Chen; Yi Zeng; Xiao-Ming Shi
Journal:  J Am Med Dir Assoc       Date:  2018-05-25       Impact factor: 4.669

5.  Predictive value of weight loss on mortality of HIV-positive mothers in a prolonged breastfeeding setting.

Authors:  Ai Koyanagi; Jean H Humphrey; Lawrence H Moulton; Robert Ntozini; Kuda Mutasa; Peter Iliff; Andrea J Ruff
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-16       Impact factor: 2.205

Review 6.  Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings.

Authors:  John R Koethe; Benjamin H Chi; Karen M Megazzini; Douglas C Heimburger; Jeffrey S A Stringer
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

7.  Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.

Authors:  Anne F Luetkemeyer; Susan L Rosenkranz; Darlene Lu; Florence Marzan; Prudence Ive; Evelyn Hogg; Susan Swindells; Constance A Benson; Beatriz Grinsztejn; Ian M Sanne; Diane V Havlir; Francesca Aweeka
Journal:  Clin Infect Dis       Date:  2013-04-16       Impact factor: 9.079

8.  Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting.

Authors:  Patricia E Molina; Charles H Lang; Margaret McNurlan; Gregory J Bagby; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2007-11-20       Impact factor: 3.455

9.  Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.

Authors:  Ross J Harris; Jonathan A C Sterne; Sophie Abgrall; François Dabis; Peter Reiss; Michael Saag; Andrew N Phillips; Geneviève Chêne; John M Gill; Amy C Justice; Jürgen Rockstroh; Caroline A Sabin; Amanda Mocroft; Heiner C Bucher; Robert S Hogg; Antonella D'Arminio Monforte; Margaret May; Matthias Egger
Journal:  Antivir Ther       Date:  2008

10.  The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.

Authors:  Brian K Kigozi; Samwel Sumba; Peter Mudyope; Betty Namuddu; Joan Kalyango; Charles Karamagi; Mathew Odere; Elly Katabira; Peter Mugyenyi; Francis Ssali
Journal:  AIDS Res Ther       Date:  2009-07-24       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.